Therapeutic Approaches and Efficacy of von Willebrand Factor in von Willebrand Disease Treatment

This systematic review evaluates therapeutic approaches for von Willebrand Disease (VWD), focusing on the role of von Willebrand factor (VWF) in treatment. Using the Synthory.AI service, the review adheres to PRISMA guidelines, analyzing studies from 2010 to 2024. Seven articles were included, emphasizing VWF's role in stabilizing factor VIII, which enhances treatment efficacy and reduces bleeding episodes. Despite promising results, variability in patient response and methodological limitations necessitate individualized treatment strategies and further research. Future studies should adopt prospective designs with larger, diverse populations to improve therapeutic strategies and patient outcomes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-01
DOI
https://doi.org/10.5281/zenodo.14963253
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Approaches and Efficacy of von Willebrand Factor in von Willebrand Disease Treatment

Zenodo (CERN European Organization for Nuclear Research)
Gastric Cancer Management and Outcomes
article

Therapeutic Approaches and Efficacy of von Willebrand Factor in von Willebrand Disease Treatment

article en

Abstract

This systematic review evaluates therapeutic approaches for von Willebrand Disease (VWD), focusing on the role of von Willebrand factor (VWF) in treatment. Using the Synthory.AI service, the review adheres to PRISMA guidelines, analyzing studies from 2010 to 2024. Seven articles were included, emphasizing VWF's role in stabilizing factor VIII, which enhances treatment efficacy and reduces bleeding episodes. Despite promising results, variability in patient response and methodological limitations necessitate individualized treatment strategies and further research. Future studies should adopt prospective designs with larger, diverse populations to improve therapeutic strategies and patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 38%
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.